Bunkerhill Health

We’re pleased to welcome FIDI - Funda??o Instituto de Pesquisa e Estudo de Diagnóstico por Imagem to the Bunkerhill Health consortium as a key collaborator on our foundation model—an AI platform designed to transform patient care across multiple specialties. With partners like FIDI, we’re building smarter, faster tools that bring insights from diverse institutions directly to providers, empowering earlier interventions and more precise care. Our foundation model is designed to adapt and scale without constant retraining, making innovation more efficient and impactful. Welcome, FIDI! Together, we’re shaping the future of clinical AI. Read more here: https://lnkd.in/gF-wFBwH #BunkerhillHealth #ClinicalAI #HealthcareInnovation

Hi Everyone! Bunkerhill Health is hiring a Customer Success Manager. The role will report to David Wen and he is the most passionate, hilarious, and fun loving person ever! If you're interested, please apply here: https://lnkd.in/gqeEGA2f

We couldn’t do what we do without the support of our incredible partners! Today, we’re celebrating the institutions that make up the Bunkerhill Health consortium, including institutions like Stanford University School of Medicine, University of California, San Francisco, and Emory University. #HealthcareInnovation #AIinMedicine #CardiovascularCare

?? Exciting News from Bunkerhill Health ?? We proudly announce that our CAC (Gated) device has received FDA clearance! ?? https://lnkd.in/eC3AjrdU This cutting-edge technology uses a fully automated, end-to-end deep learning algorithm to analyze gated, non-contrast cardiac CT scans. It provides precise coronary artery calcium (CAC) scoring, with vessel-specific Agatston scores for key arteries, empowering clinicians with comprehensive data. As highlighted in this ACC article by Roger Blumenthal, Miguel Cainzos-Achirica, MD MPH PhD, and Andrew Gagel, "the use of CAC in primary prevention is supported by a wealth of data showing that it improves risk prediction when combined with traditional risk factors and scores." ?? https://lnkd.in/eA9tKHB7 We’re excited about this technology's impact on improving cardiovascular care! #HealthTech #Cardiology #Innovation #FDAClearance #Healthcare

Bunkerhill Health is proud to partner with Stamford Health to bring our cutting-edge, AI-powered cardiovascular screening algorithm to patients in Connecticut! This advanced technology automatically runs during non-gated chest CT scans, providing precise coronary artery calcium (CAC) scores that can identify early signs of cardiovascular disease. Integrating AI into routine imaging enables providers to deliver personalized, timely follow-up care and helps patients manage their heart health proactively. This partnership is a major step in transforming cardiovascular care, ensuring patients receive the best treatment options before conditions worsen. We’re excited to see this technology in action and continue advancing healthcare with our partners! https://lnkd.in/ecFFETQq #ArtificialIntelligence #HealthTech #DigitalHealth #HealthcareInnovation #AIinHealthcare #Cardiology #HeartHealth #CardiovascularHealth

Don't miss AIMI NextGen Tech Talk Episode 5 on Aug. 26 with health AI entrepreneur and AIMI alumnus Nishith Khandwala, co-founder of Bunkerhill Health. This episode will will explore startups and innovations in the health AI space. Registration (free & open to all): https://bit.ly/4dKKVfD About Our NextGen Tech Talks:? AIMI NextGen Tech Talks are a live webinar series tailored towards high school students eager to explore the field of AI in medicine and health. Hear from renowned experts in the field as they share their professional journeys to shaping the future of healthcare with technology! Attendees will have an opportunity to participate in a live webinar Q&A with the speakers. https://lnkd.in/gzsYffmH Can't make it? A recording will also be available on our YouTube channel: https://bit.ly/3SWw4Gd #NextGenTechTalk #AIInMedicine #HealthAI #AIInnovation

Don't miss AIMI NextGen Tech Talk Episode 5 on Aug. 26 with health AI entrepreneur and AIMI alumnus Nishith Khandwala, co-founder of Bunkerhill Health. This episode will will explore startups and innovations in the health AI space. Registration (free & open to all): https://bit.ly/4dKKVfD About Our NextGen Tech Talks:? AIMI NextGen Tech Talks are a live webinar series tailored towards high school students eager to explore the field of AI in medicine and health. Hear from renowned experts in the field as they share their professional journeys to shaping the future of healthcare with technology! Attendees will have an opportunity to participate in a live webinar Q&A with the speakers. https://lnkd.in/gzsYffmH Can't make it? A recording will also be available on our YouTube channel: https://bit.ly/3SWw4Gd #NextGenTechTalk #AIInMedicine #HealthAI #AIInnovation

?? Prevalence of Coronary Atherosclerosis Among Patients Classified as Low Risk Peter Attia's analysis this week of research by Kamil Faridi, Matthew Budoff, Jack Ziffer, PhD, MD, FACC,FACR,FAHA,FASNC,MSCCT, Khurram Nasir, MD MPH MSc, Miguel Cainzos-Achirica, MD MPH PhD and others highlights the following: "Despite their evident “low risk” status,?over one third?(35.9%) of participants included in the analysis were found to have coronary plaque, while roughly one quarter (25.3%) had a CAC score over zero – an indication of the presence of early-stage?artery calcification. Additionally, a smaller set of participants were found to have more advanced CVD, with 4.5% having CAC scores ≥100 (indicating moderate disease), 3.4% showing evidence of high-risk plaque, and 1.9% demonstrating artery blockage of at least 50% according to CCTA scans." By scoring incidental Coronary Artery Calcium in routine screenings, clinicians can proactively identify at-risk patients and optimize treatment strategies to minimize disease progression and the risk of heart attack, stroke, and cardiac death. The analysis concludes: "Thus, we return to the question posed at the start of this piece – why is atherosclerotic cardiovascular disease so deadly despite the existence of effective treatments? The results of the present study suggest a simple (albeit alarming) answer: millions of individuals with this disease are likely unaware of it." https://lnkd.in/d2g-Jiy4 #cardiovascularhealth #heartdisease #prevention #healthcareai

?? Prevalence of Coronary Atherosclerosis Among Patients Classified as Low Risk Peter Attia's analysis this week of research by Kamil Faridi, Matthew Budoff, Jack Ziffer, PhD, MD, FACC,FACR,FAHA,FASNC,MSCCT, Khurram Nasir, MD MPH MSc, Miguel Cainzos-Achirica, MD MPH PhD and others highlights the following: "Despite their evident “low risk” status,?over one third?(35.9%) of participants included in the analysis were found to have coronary plaque, while roughly one quarter (25.3%) had a CAC score over zero – an indication of the presence of early-stage?artery calcification. Additionally, a smaller set of participants were found to have more advanced CVD, with 4.5% having CAC scores ≥100 (indicating moderate disease), 3.4% showing evidence of high-risk plaque, and 1.9% demonstrating artery blockage of at least 50% according to CCTA scans." By scoring incidental Coronary Artery Calcium in routine screenings, clinicians can proactively identify at-risk patients and optimize treatment strategies to minimize disease progression and the risk of heart attack, stroke, and cardiac death. The analysis concludes: "Thus, we return to the question posed at the start of this piece – why is atherosclerotic cardiovascular disease so deadly despite the existence of effective treatments? The results of the present study suggest a simple (albeit alarming) answer: millions of individuals with this disease are likely unaware of it." https://lnkd.in/d2g-Jiy4 #cardiovascularhealth #heartdisease #prevention #healthcareai